Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity
Open Access
- 1 June 2003
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 278 (26), 24113-24117
- https://doi.org/10.1074/jbc.m301716200
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)Human Molecular Genetics, 2001
- Mutation and Analysis of Dan, the Founding Member of the Dan Family of Transforming Growth Factor β AntagonistsMolecular and Cellular Biology, 2001
- Bone DevelopmentAnnual Review of Cell and Developmental Biology, 2000
- Structure and Expression of a Novel Member, FGF-16, of the Fibroblast Growth Factor FamilyBiochemical and Biophysical Research Communications, 1998
- Differentiation and Transforming Growth Factor-β Receptor Down-regulation by Collagen-α2β1 Integrin Interaction Is Mediated by Focal Adhesion Kinase and Its Downstream Signals in Murine Osteoblastic CellsOnline Journal of Public Health Informatics, 1997
- Bone morphogenetic proteins: multifunctional regulators of vertebrate development.Genes & Development, 1996
- Cystine knotsCurrent Opinion in Structural Biology, 1995
- Bone and cartilage differentiationCurrent Opinion in Genetics & Development, 1994
- Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cellsJournal of Bone and Mineral Research, 1994
- High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse developmentThe Journal of cell biology, 1994